These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9952265)

  • 1. Influence of valproate monotherapy on platelet activation and hematologic values.
    Zeller JA; Schlesinger S; Runge U; Kessler C
    Epilepsia; 1999 Feb; 40(2):186-9. PubMed ID: 9952265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate treatment and platelet function: the role of arachidonate metabolites.
    Kis B; Szupera Z; Mezei Z; Gecse A; Telegdy G; Vécsei L
    Epilepsia; 1999 Mar; 40(3):307-10. PubMed ID: 10080510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
    Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
    Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration.
    Gidal B; Spencer N; Maly M; Pitterle M; Williams E; Collins M; Jones J
    Neurology; 1994 Aug; 44(8):1418-22. PubMed ID: 8058141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro- and anticoagulatory factors under sodium valproate-therapy in children.
    Banerjea MC; Diener W; Kutschke G; Schneble HJ; Korinthenberg R; Sutor AH
    Neuropediatrics; 2002 Aug; 33(4):215-20. PubMed ID: 12368993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditory event related potentials in patients with epilepsy on sodium valproate monotherapy.
    Panagopoulos GR; Thomaides T; Tagaris G; Karageorgiou CL
    Acta Neurol Scand; 1997 Jul; 96(1):62-4. PubMed ID: 9262135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis.
    Zighetti ML; Fontana G; Lussana F; Chiesa V; Vignoli A; Canevini MP; Cattaneo M
    Epilepsia; 2015 May; 56(5):e49-52. PubMed ID: 25757394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein C, protein S and other pro- and anticoagulant activities among epileptic children using sodium valproate.
    Ugras M; Yakinci C
    Brain Dev; 2006 Oct; 28(9):549-53. PubMed ID: 16842952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of antiepileptic drug therapy on antioxidant enzyme activity and serum lipid peroxidation in young patients with epilepsy].
    Sołowiej E; Sobaniec W
    Neurol Neurochir Pol; 2003; 37(5):991-1003. PubMed ID: 15174247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate.
    Cansu A; Serdaroğlu A; Camurdan O; Hirfanoğlu T; Bideci A; Gücüyener K
    Epilepsia; 2006 Nov; 47(11):1855-9. PubMed ID: 17116024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine effects of valproate in adolescent girls with epilepsy.
    de Vries L; Karasik A; Landau Z; Phillip M; Kiviti S; Goldberg-Stern H
    Epilepsia; 2007 Mar; 48(3):470-7. PubMed ID: 17326798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
    Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
    Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid function in children with epilepsy treated with sodium valproate monotherapy: a prospective study.
    Attilakos A; Katsarou E; Prassouli A; Mastroyianni S; Voudris K; Fotinou A; Garoufi A
    Clin Neuropharmacol; 2009; 32(1):32-4. PubMed ID: 18978499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of sodium valproate on neutrophils' oxidative metabolism and oxidant status in children with idiopathic epilepsy].
    Zhang YJ; Zhang M; Wang XC; Yu YH; Jin PJ; Wang Y
    Zhonghua Er Ke Za Zhi; 2011 Oct; 49(10):776-81. PubMed ID: 22321186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monotherapy and concomitant therapy.
    Rosenfeld WE; Liao S; Kramer LD; Anderson G; Palmer M; Levy RH; Nayak RK
    Epilepsia; 1997 Mar; 38(3):324-33. PubMed ID: 9070595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematologic manifestations and impaired liver synthetic function during valproate monotherapy.
    Hauser E; Seidl R; Freilinger M; Male C; Herkner K
    Brain Dev; 1996; 18(2):105-9. PubMed ID: 8733899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy.
    Stephen LJ; Kwan P; Shapiro D; Dominiczak M; Brodie MJ
    Epilepsia; 2001 Aug; 42(8):1002-6. PubMed ID: 11554885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS.
    Werner T; Treiss I; Kohlmueller D; Mehlem P; Teich M; Longin E; Gerstner T; Koenig SA; Schulze A
    Epilepsia; 2007 Jan; 48(1):72-6. PubMed ID: 17241210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Carbamazepine and Valproate on Serum Aspartate Aminotransferase, Alanine Aminotransferase and Gamma - Glutamyltransferase in Children.
    Hadzagic-Catibusic F; Hasanbegovic E; Melunovic M; Zubcevic S; Uzicanin S
    Med Arch; 2017 Aug; 71(4):239-242. PubMed ID: 28974841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.